Matinas BioPharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MTNB and other ETFs, options, and stocks.

About MTNB

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. 

CEO
Jerome D. Jabbour
CEOJerome D. Jabbour
Employees
7
Employees7
Headquarters
Bedminster, New Jersey
HeadquartersBedminster, New Jersey
Founded
2013
Founded2013
Employees
7
Employees7

MTNB Key Statistics

Market cap
4.32M
Market cap4.32M
Price-Earnings ratio
-0.21
Price-Earnings ratio-0.21
Dividend yield
—
Dividend yield—
Average volume
233.28K
Average volume233.28K
High today
$0.8899
High today$0.8899
Low today
$0.85
Low today$0.85
Open price
$0.888
Open price$0.888
Volume
42.74K
Volume42.74K
52 Week high
$9.60
52 Week high$9.60
52 Week low
$0.4748
52 Week low$0.4748

People also own

Based on the portfolios of people who own MTNB. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Plug Power
Tilray Brands
TherapeuticsMD
Cenntro Inc.
Organigram Global Inc.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.